American Oriental Bioengineering Completes Guangxi Boke Acquisition
Aggregated Source: Seeking Alpha China stocks
October 21, 2007|
American Oriental Bioengineering, Inc. (NYSE:AOB), a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products, announced Thursday that it has completed the acquisition of Guangxi Boke Pharmaceutical Company Limited.
Original URL: Click here to visit original article
Copyright Seeking Alpha China stocks
Print This Post
|
Email This Page